Strategic Overview

Anbio is a Chinese diagnostics company developing point-of-care molecular tests for TB with innovative sample types.

Innovation Portfolio

POCT TB Test
Category: DIAGNOSIS Stage: Late Stage

Innovative diagnostic solution.

nPOC Molecular Swab/Sputum
POCT Sputum TB/RIF
Category: DRUG RESIST. Stage: Late Stage

Innovative diagnostic solution.

Molecular Sputum

Key Milestones

POCT TB Test with tongue swab capability
95.79% sensitivity for tongue samples
POCT Sputum TB/RIF drug resistance test
Affordable cost of goods (≤$2.45-2.95)